Biomica Raises $20 Million in a Financing Round to Advance its Pipeline of Microbiome-based Therapeutics

/PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....

Related Keywords

China ,Yangtze River ,China General ,Shanghai ,Hong Kong ,Jing Bao ,Guizhou ,Chinese ,Ofer Haviv ,Cecile Cai ,Elran Haber ,Kenny Green ,Lavie Bio Ltd ,Weizmann Institute Of Science ,Biomica Ltd ,Evogene Ltd ,Nasdaq ,Agplenus Ltd ,Canonic Ltd ,Shanghai Industrial Investment Holdings Co Ltd ,Chief Executive Officer ,Senior Advisor ,Shanghai Healthcare Capital ,Weizmann Institute ,Shanghai Pharma ,Computational Predictive Biology ,Big Data ,Artificial Intelligence ,Lavie Bio ,Healthcare Capital ,Shanghai Municipal Government ,Shanghai Industrial Investment ,Yangtze River Delta ,Looking Statements ,